Back to Search Start Over

Exploring the influence of smoking and alcohol consumption on clinical severity in patients with facioscapulohumeral muscular dystrophy

Authors :
Sanne C. C. Vincenten
Karlien Mul
Corinne G.C. Horlings
Nicol C. Voermans
Tim H. A. Schreuder
Baziel G.M. van Engelen
Source :
Neuromuscular Disorders, 31, 824-828, Neuromuscular Disorders, 31, 9, pp. 824-828
Publication Year :
2021
Publisher :
Elsevier BV, 2021.

Abstract

Despite the growing knowledge on the (epi)genetic background of facioscapulohumeral muscular dystrophy (FSHD), the substantial variability in disease severity that exists between FSHD patients is not fully understood. We hypothesized that smoking and alcohol consumption are disease modifiers in FSHD and contribute to the variability in disease severity, because they are both associated with higher levels of oxidative stress in muscle tissue. Oxidative stress is known to influence FSHD muscle tissue. One hundred and ninety-eight genetically confirmed FSHD patients completed a questionnaire from which the number of packyears of smoking and the lifetime cumulative alcohol units consumed were calculated. Disease severity was determined by the FSDH evaluation score. Multiple linear regression analyses showed that both the number of packyears and the amount of alcohol consumption did not influence disease severity (respectively B = 0.025, ΔR2=0.006, p = 0.231; and B = 0.000, ΔR2=0.004, p = 0.406). Although smoking and excessive alcohol consumption are unhealthy habits which should be discouraged, these results show that smoking and alcohol consumption have no clinically meaningful modifying effect on disease severity in FSHD patients. However, prospective data should show whether alcohol consumption and smoking influence disease progression rate.

Details

ISSN :
09608966
Volume :
31
Database :
OpenAIRE
Journal :
Neuromuscular Disorders
Accession number :
edsair.doi.dedup.....a4700eddd739cfa211830ca544043a43
Full Text :
https://doi.org/10.1016/j.nmd.2021.07.005